Stock IKT INHIBIKASE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Inhibikase Therapeutics, Inc.

Equities

IKT

US45719W2052

Market Closed - Nasdaq
Other stock markets
 15:59:50 2024-05-24 EDT 		5-day change 1st Jan Change
1.81 USD -1.09% Intraday chart for Inhibikase Therapeutics, Inc. +4.62% +42.52%
05-21 HC Wainwright Adjusts Inhibikase Therapeutics Price Target to $23 From $27, Maintains Buy Rating MT
05-16 Transcript : Inhibikase Therapeutics, Inc., Q1 2024 Earnings Call, May 16, 2024

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
INHIBIKASE THERAPEUTICS, INC.
Other Biotechnology & Medical Research
-1.09%+4.62%+42.52%-52.86% - 13.16M
Neutral
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. IKT Stock
  4. Charts Inhibikase Therapeutics, Inc.
  5. Relative Strength Chart